PR001275 (Project)

Dcc Asset:

MW submission packet 20260310.zip

Processed File (Entity type)

Dcc:

Metabolomics

DCC (Entity type)

Child Project:

PPR00001

Project (Entity type)

Persistent Id:http://dx.doi.org/10.21228/M8WX21

Description:Here we interrogated the in vitro metabolic effects of 6 drugs using ultra-high performance liquid chromatography mass-spectrometry (UHPLC-MS). The resulting metabolic fingerprints provide information on the parasite biochemical pathways affected by pharmacologic intervention and offer a critical blueprint for selecting and advancing lead compounds as next-generation antimalarial drugs. Our results reveal several distinctions between compounds with polypharmacological effects.

Results found

Linked to

	Label	Description
	SA188336 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188328 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188323 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SU002092 Subject (Entity type)	A subject produced as part of the PR001275 project
	SA188339 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188333 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188332 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188329 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188331 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project
	SA188340 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR001275 project